Skip to content

Chemotherapy drugs are known to cause numerous side effects, of which memory loss and heart problems are of great concern. In this study, we are trying to find the effectiveness of 18-week yoga practice on memory loss and heart problems in breast cancer patients who are undergoing chemotherapy.

Effects of Integrated Yoga Therapy on Cognition and Cardiac functions in patients with Breast Carcinoma undergoing Chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028446
Enrollment
150
Registered
2020-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D249- Benign neoplasm of unspecified breast

Interventions

Intervention1: Yoga therapy: Integrated yoga therapy (which includes asanas, pranayama, meditation, and relaxation) for 18 weeks (i.e.) during six chemotherapy cycles. Control Intervention1: Not appli

Sponsors

Central Council for Research in Yoga and Naturopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Early-stage II and III breast cancer patients; 2)Scheduled to undergo at least six cycles of chemotherapy; 3)High school education with the ability to read and write English (to perform neuropsychological assessments)

Exclusion criteria

Exclusion criteria: 1)Neurological disorders such as any significant head injury, epilepsy, Parkinsonâ??s disease, neurodegenerative disorders, etc. ;2)Uncontrolled diabetes, hypertension, and autoimmune diseases; 3)Patients with prior h/o depression, major psychiatric illness, and Alzheimerâ??s disease and on medication; 4)Brain metastases; 5)Cases with anemia (Hemoglobin < 10gm %); 6)H/o of existing cardiac disease/patients with a cardiac pacemaker; 7)Concurrent medical condition/s likely to influence survival; 8)H/o recent infections or fever in the past two weeks; 9)Regular participation in an active behavioural intervention/yoga in last six months.

Design outcomes

Primary

MeasureTime frame
Role of yoga in evaluating Neuropsychological test assessment and Heart rate variability in breast cancer patients undergoing chemotherapyTimepoint: Two time points 1) Baseline 2) Post 18 weeks

Secondary

MeasureTime frame
Echocardiography; Brain-derived Neurotrophic factor; Cortisol; Self reported EORTC QLQ C30; Perceived stress scale; Psychological wellbeingTimepoint: Two time points 1) Baseline 2) Post 18 weeks

Countries

India

Contacts

Public ContactDr Kaviraja Udupa

National Institute of Mental Health & Neurosciences

drsathyaprabha@gmail.com9845298112

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 11, 2026